137 related articles for article (PubMed ID: 22829154)
1. A new hypothesis: imatinib affects leukemic stem cells in the same way it affects all other leukemic cells.
Tomasetti C
Blood Cancer J; 2011 May; 1(5):e19. PubMed ID: 22829154
[No Abstract] [Full Text] [Related]
2. Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.
Foo J; Drummond MW; Clarkson B; Holyoake T; Michor F
PLoS Comput Biol; 2009 Sep; 5(9):e1000503. PubMed ID: 19749982
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of chronic myeloid leukemia response to long-term targeted therapy reveal treatment effects on leukemic stem cells.
Tang M; Gonen M; Quintas-Cardama A; Cortes J; Kantarjian H; Field C; Hughes TP; Branford S; Michor F
Blood; 2011 Aug; 118(6):1622-31. PubMed ID: 21653938
[TBL] [Abstract][Full Text] [Related]
4. Implication of the Autologous Immune System in BCR-ABL Transcript Variations in Chronic Myelogenous Leukemia Patients Treated with Imatinib.
Clapp GD; Lepoutre T; El Cheikh R; Bernard S; Ruby J; Labussière-Wallet H; Nicolini FE; Levy D
Cancer Res; 2015 Oct; 75(19):4053-62. PubMed ID: 26359456
[TBL] [Abstract][Full Text] [Related]
5. Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells.
Kluza J; Jendoubi M; Ballot C; Dammak A; Jonneaux A; Idziorek T; Joha S; Dauphin V; Malet-Martino M; Balayssac S; Maboudou P; Briand G; Formstecher P; Quesnel B; Marchetti P
PLoS One; 2011; 6(7):e21924. PubMed ID: 21789194
[TBL] [Abstract][Full Text] [Related]
6. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.
Hu Y; Swerdlow S; Duffy TM; Weinmann R; Lee FY; Li S
Proc Natl Acad Sci U S A; 2006 Nov; 103(45):16870-5. PubMed ID: 17077147
[TBL] [Abstract][Full Text] [Related]
7. BCR-ABL transcript dynamics support the hypothesis that leukemic stem cells are reduced during imatinib treatment.
Stein AM; Bottino D; Modur V; Branford S; Kaeda J; Goldman JM; Hughes TP; Radich JP; Hochhaus A
Clin Cancer Res; 2011 Nov; 17(21):6812-21. PubMed ID: 21903771
[TBL] [Abstract][Full Text] [Related]
8. Chronic myeloid leukemia blast crisis arises from progenitors.
Michor F
Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
[TBL] [Abstract][Full Text] [Related]
9. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
Hu Y; Chen Y; Douglas L; Li S
Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells.
Kim JE; Yoon S; Choi BR; Kim KP; Cho YH; Jung W; Kim DW; Oh S; Kim DE
Leukemia; 2013 Aug; 27(8):1650-8. PubMed ID: 23434731
[TBL] [Abstract][Full Text] [Related]
11. Differences between in vivo and in vitro sensitivity to imatinib of Bcr/Abl+ cells obtained from leukemic patients.
Gambacorti-Passerini CB; Rossi F; Verga M; Ruchatz H; Gunby R; Frapolli R; Zucchetti M; Scapozza L; Bungaro S; Tornaghi L; Rossi F; Pioltelli P; Pogliani E; D'Incalci M; Corneo G
Blood Cells Mol Dis; 2002; 28(3):361-72. PubMed ID: 12367580
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).
Nies AT; Schaeffeler E; van der Kuip H; Cascorbi I; Bruhn O; Kneba M; Pott C; Hofmann U; Volk C; Hu S; Baker SD; Sparreboom A; Ruth P; Koepsell H; Schwab M
Clin Cancer Res; 2014 Feb; 20(4):985-94. PubMed ID: 24352644
[TBL] [Abstract][Full Text] [Related]
13. Leukemic cells with increased telomerase activity exhibit resistance to imatinib.
Yamada O; Kawauchi K; Akiyama M; Ozaki K; Motoji T; Adachi T; Aikawa E
Leuk Lymphoma; 2008 Jun; 49(6):1168-77. PubMed ID: 18569639
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells.
Kaehler M; Ruemenapp J; Gonnermann D; Nagel I; Bruhn O; Haenisch S; Ammerpohl O; Wesch D; Cascorbi I; Bruckmueller H
Oncotarget; 2017 Nov; 8(54):92018-92031. PubMed ID: 29190894
[TBL] [Abstract][Full Text] [Related]
15. Revealing genome-wide mRNA and microRNA expression patterns in leukemic cells highlighted "hsa-miR-2278" as a tumor suppressor for regain of chemotherapeutic imatinib response due to targeting STAT5A.
Kaymaz BT; Günel NS; Ceyhan M; Çetintaş VB; Özel B; Yandım MK; Kıpçak S; Aktan Ç; Gökbulut AA; Baran Y; Can BK
Tumour Biol; 2015 Sep; 36(10):7915-27. PubMed ID: 25953263
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Imatinib Resistant CML Leukemic Stem/Initiating Cells and Their Sensitivity to CBP/Catenin Antagonists.
Zhao Y; Wu K; Wu Y; Melendez E; Smbatyan G; Massiello D; Kahn M
Curr Mol Pharmacol; 2018; 11(2):113-121. PubMed ID: 28933312
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features.
Tusa I; Cheloni G; Poteti M; Silvano A; Tubita A; Lombardi Z; Gozzini A; Caporale R; Scappini B; Dello Sbarba P; Rovida E
Target Oncol; 2020 Oct; 15(5):659-671. PubMed ID: 32780298
[TBL] [Abstract][Full Text] [Related]
18. CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI.
Moreno-Lorenzana D; Avilés-Vazquez S; Sandoval Esquivel MA; Alvarado-Moreno A; Ortiz-Navarrete V; Torres-Martínez H; Ayala-Sánchez M; Mayani H; Chavez-Gonzalez A
Cell Cycle; 2016 May; 15(9):1276-87. PubMed ID: 26985855
[TBL] [Abstract][Full Text] [Related]
19. Signaling pathways in chronic myeloid leukemia and leukemic stem cell maintenance: key role of stromal microenvironment.
Seke Etet PF; Vecchio L; Nwabo Kamdje AH
Cell Signal; 2012 Sep; 24(9):1883-8. PubMed ID: 22659137
[TBL] [Abstract][Full Text] [Related]
20. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
